IN
INNOCAN PHARMA Corp
INNPF · OTC
$1.62 -7.43% (-$0.13)
1M +9.46%
Market Cap $7.20M
P/E Ratio -
Div. Yield -
ROE 13.58%
Analysis
An AI report on the business, its finances, valuation, sentiment, news and risks - written in a few minutes.
Piotroski F-Score Weak
3/9Valuation
99 /100
Cheap P/S 0.24x
P/B 1.71x
EV/EBITDA 1.14x
Growth
-
N/A Rev. growth N/A
FCF growth N/A
Book val. growth N/A
Profitability
22 /100
Weak Net margin 2.21%
Op. margin 1.22%
FCF margin 0.54%
Quality
17 /100
Poor ROE 13.58%
ROA 5.95%
Asset turnover 2.69x
Debt
99 /100
Low Current ratio 3.70x
Int. coverage 126.33x
Net debt/EBITDA -5.00x
Stability
50 /100
Moderate Beta -0.22x
EPS volatility N/A
Profitable years N/A
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about INNPF
Online
Sector
Healthcare
Industry
Medical - Pharmaceuticals
CEO
Iris Bincovich
Employees
11
Headquarters
Calgary